APO Research
Talk to an analyst

APO RESEARCH · REPORT

Healthcare Infection Surveillance Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Healthcare Infection Surveillance Service Market Analysis and Forecast 2026-2032

6 March 2026193 pages

Choose your research edition.

Industry ResearchHealthcare Infection Surveillance Service Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Healthcare Infection Surveillance Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Healthcare Infection Surveillance Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Healthcare Infection Surveillance Service Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Healthcare Infection Surveillance Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Healthcare Infection Surveillance Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Healthcare Infection Surveillance Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Healthcare Infection Surveillance Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Healthcare Infection Surveillance Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Healthcare Infection Surveillance Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Healthcare Infection Surveillance Service include Baxter International Inc., Wolters Kluwer, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., Alpha Source Inc., RLDatixS. C., BD and BioVigil, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Healthcare Infection Surveillance Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Healthcare Infection Surveillance Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Healthcare Infection Surveillance Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Healthcare Infection Surveillance Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Healthcare Infection Surveillance Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Healthcare Infection Surveillance Service revenue, projected growth trends, production technology, application and end-user industry.

Healthcare Infection Surveillance Service Segment by Company

Baxter International Inc.

Wolters Kluwer

Gojo Industries Inc.

International Business Machines Corporation

Premier Inc.

Alpha Source Inc.

RLDatixS. C.

BD

BioVigil

Johnson & Son

Healthcare Infection Surveillance Service Segment by Type

Bloodstream Infections

Surgical Site Infections

Gastrointestinal Infections

Urinary Tract Infections (UTI)

Others

Healthcare Infection Surveillance Service Segment by Application

Hospitals & Clinics

Ambulatory Surgical Centers

Academic Institutes

Others

Healthcare Infection Surveillance Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Healthcare Infection Surveillance Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Healthcare Infection Surveillance Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Healthcare Infection Surveillance Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Healthcare Infection Surveillance Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Healthcare Infection Surveillance Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Healthcare Infection Surveillance Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bloodstream Infections Major Player Table 3. Surgical Site Infections Major Player Table 4. Gastrointestinal Infections Major Player Table 5. Urinary Tract Infections (UTI) Major Player Table 6. Others Major Player Table 7. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals & Clinics Major Player Table 9. Ambulatory Surgical Centers Major Player Table 10. Academic Institutes Major Player Table 11. Others Major Player Table 12. Healthcare Infection Surveillance Service Industry Trends Table 13. Healthcare Infection Surveillance Service Industry Drivers Table 14. Healthcare Infection Surveillance Service Industry Opportunities and Challenges Table 15. Healthcare Infection Surveillance Service Industry Restraints Table 16. Global Healthcare Infection Surveillance Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Healthcare Infection Surveillance Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Healthcare Infection Surveillance Service Market Share by Region (2021-2026) Table 19. Global Healthcare Infection Surveillance Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Healthcare Infection Surveillance Service Market Share by Region (2027-2032) Table 21. Global Healthcare Infection Surveillance Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Healthcare Infection Surveillance Service Revenue Market Share by Players (2021-2026) Table 23. Global Healthcare Infection Surveillance Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Healthcare Infection Surveillance Service Key Players Headquarters & Area Served Table 25. Global Healthcare Infection Surveillance Service Players, Product Type & Application Table 26. Global Healthcare Infection Surveillance Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Healthcare Infection Surveillance Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Healthcare Infection Surveillance Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Healthcare Infection Surveillance Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Healthcare Infection Surveillance Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Healthcare Infection Surveillance Service Revenue Market Share by Type (2021-2026) Table 33. Global Healthcare Infection Surveillance Service Revenue Market Share by Type (2027-2032) Table 34. Global Healthcare Infection Surveillance Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Healthcare Infection Surveillance Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Healthcare Infection Surveillance Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Healthcare Infection Surveillance Service Revenue Market Share by Application (2021-2026) Table 38. Global Healthcare Infection Surveillance Service Revenue Market Share by Application (2027-2032) Table 39. Baxter International Inc. Company Information Table 40. Baxter International Inc. Business Overview Table 41. Baxter International Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Baxter International Inc. Healthcare Infection Surveillance Service Product Portfolio Table 43. Baxter International Inc. Recent Development Table 44. Wolters Kluwer Company Information Table 45. Wolters Kluwer Business Overview Table 46. Wolters Kluwer Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Wolters Kluwer Healthcare Infection Surveillance Service Product Portfolio Table 48. Wolters Kluwer Recent Development Table 49. Gojo Industries Inc. Company Information Table 50. Gojo Industries Inc. Business Overview Table 51. Gojo Industries Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Gojo Industries Inc. Healthcare Infection Surveillance Service Product Portfolio Table 53. Gojo Industries Inc. Recent Development Table 54. International Business Machines Corporation Company Information Table 55. International Business Machines Corporation Business Overview Table 56. International Business Machines Corporation Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. International Business Machines Corporation Healthcare Infection Surveillance Service Product Portfolio Table 58. International Business Machines Corporation Recent Development Table 59. Premier Inc. Company Information Table 60. Premier Inc. Business Overview Table 61. Premier Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Premier Inc. Healthcare Infection Surveillance Service Product Portfolio Table 63. Premier Inc. Recent Development Table 64. Alpha Source Inc. Company Information Table 65. Alpha Source Inc. Business Overview Table 66. Alpha Source Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Alpha Source Inc. Healthcare Infection Surveillance Service Product Portfolio Table 68. Alpha Source Inc. Recent Development Table 69. RLDatixS. C. Company Information Table 70. RLDatixS. C. Business Overview Table 71. RLDatixS. C. Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. RLDatixS. C. Healthcare Infection Surveillance Service Product Portfolio Table 73. RLDatixS. C. Recent Development Table 74. BD Company Information Table 75. BD Business Overview Table 76. BD Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BD Healthcare Infection Surveillance Service Product Portfolio Table 78. BD Recent Development Table 79. BioVigil Company Information Table 80. BioVigil Business Overview Table 81. BioVigil Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. BioVigil Healthcare Infection Surveillance Service Product Portfolio Table 83. BioVigil Recent Development Table 84. Johnson & Son Company Information Table 85. Johnson & Son Business Overview Table 86. Johnson & Son Healthcare Infection Surveillance Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Johnson & Son Healthcare Infection Surveillance Service Product Portfolio Table 88. Johnson & Son Recent Development Table 89. North America Healthcare Infection Surveillance Service Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Healthcare Infection Surveillance Service Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Healthcare Infection Surveillance Service Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Healthcare Infection Surveillance Service Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Healthcare Infection Surveillance Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Healthcare Infection Surveillance Service Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Healthcare Infection Surveillance Service Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Healthcare Infection Surveillance Service Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Healthcare Infection Surveillance Service Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Healthcare Infection Surveillance Service Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Healthcare Infection Surveillance Service Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Healthcare Infection Surveillance Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Healthcare Infection Surveillance Service Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Healthcare Infection Surveillance Service Revenue by Country (US$ Million) & (2027-2032) Table 103. China Healthcare Infection Surveillance Service Revenue by Type (2021-2026) & (US$ Million) Table 104. China Healthcare Infection Surveillance Service Revenue by Type (2027-2032) & (US$ Million) Table 105. China Healthcare Infection Surveillance Service Revenue by Application (2021-2026) & (US$ Million) Table 106. China Healthcare Infection Surveillance Service Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Healthcare Infection Surveillance Service Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Healthcare Infection Surveillance Service Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Healthcare Infection Surveillance Service Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Healthcare Infection Surveillance Service Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Healthcare Infection Surveillance Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Healthcare Infection Surveillance Service Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Healthcare Infection Surveillance Service Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Healthcare Infection Surveillance Service Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Healthcare Infection Surveillance Service Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Healthcare Infection Surveillance Service Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Healthcare Infection Surveillance Service Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Healthcare Infection Surveillance Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Healthcare Infection Surveillance Service Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Healthcare Infection Surveillance Service Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Healthcare Infection Surveillance Service Image Figure 2. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Healthcare Infection Surveillance Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bloodstream Infections Image Figure 5. Surgical Site Infections Image Figure 6. Gastrointestinal Infections Image Figure 7. Urinary Tract Infections (UTI) Image Figure 8. Others Image Figure 9. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Healthcare Infection Surveillance Service Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals & Clinics Image Figure 12. Ambulatory Surgical Centers Image Figure 13. Academic Institutes Image Figure 14. Others Image Figure 15. Global Healthcare Infection Surveillance Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Healthcare Infection Surveillance Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Healthcare Infection Surveillance Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Healthcare Infection Surveillance Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Healthcare Infection Surveillance Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Healthcare Infection Surveillance Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Healthcare Infection Surveillance Service Revenue Market Share by Type (2021-2032) Figure 23. Global Healthcare Infection Surveillance Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Healthcare Infection Surveillance Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Healthcare Infection Surveillance Service Revenue Market Share by Application (2021-2032) Figure 26. North America Healthcare Infection Surveillance Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032) Figure 28. North America Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032) Figure 29. North America Healthcare Infection Surveillance Service Revenue Share by Country (2021-2032) Figure 30. United States Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Healthcare Infection Surveillance Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032) Figure 35. Europe Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032) Figure 36. Europe Healthcare Infection Surveillance Service Revenue Share by Country (2021-2032) Figure 37. Germany Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Healthcare Infection Surveillance Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032) Figure 47. China Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032) Figure 48. Asia Healthcare Infection Surveillance Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032) Figure 50. Asia Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032) Figure 51. Asia Healthcare Infection Surveillance Service Revenue Share by Region (2021-2032) Figure 52. Japan Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Healthcare Infection Surveillance Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Healthcare Infection Surveillance Service Revenue Share by Country (2021-2032) Figure 62. Brazil Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Healthcare Infection Surveillance Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others
Applications
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Academic Institutes
  • Others
Companies covered
  • Baxter International Inc.
  • Wolters Kluwer
  • Gojo Industries Inc.
  • International Business Machines Corporation
  • Premier Inc.
  • Alpha Source Inc.
  • RLDatixS. C.
  • BD
  • BioVigil
  • Johnson & Son

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Healthcare Infection Surveillance Service Market by Type
  3. 1.2.1 Global Healthcare Infection Surveillance Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bloodstream Infections
  5. 1.2.3 Surgical Site Infections
  6. 1.2.4 Gastrointestinal Infections
  7. 1.2.5 Urinary Tract Infections (UTI)
  8. 1.2.6 Others
  9. 1.3 Healthcare Infection Surveillance Service Market by Application
  10. 1.3.1 Global Healthcare Infection Surveillance Service Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals & Clinics
  12. 1.3.3 Ambulatory Surgical Centers
  13. 1.3.4 Academic Institutes
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Healthcare Infection Surveillance Service Market Dynamics
  1. 2.1 Healthcare Infection Surveillance Service Industry Trends
  2. 2.2 Healthcare Infection Surveillance Service Industry Drivers
  3. 2.3 Healthcare Infection Surveillance Service Industry Opportunities and Challenges
  4. 2.4 Healthcare Infection Surveillance Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Healthcare Infection Surveillance Service Market Perspective (2021-2032)
  2. 3.2 Global Healthcare Infection Surveillance Service Growth Trends by Region
  3. 3.2.1 Global Healthcare Infection Surveillance Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Healthcare Infection Surveillance Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Healthcare Infection Surveillance Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Healthcare Infection Surveillance Service Revenue by Players
  2. 4.1.1 Global Healthcare Infection Surveillance Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Healthcare Infection Surveillance Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Healthcare Infection Surveillance Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Healthcare Infection Surveillance Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Healthcare Infection Surveillance Service Key Players Headquarters & Area Served
  7. 4.4 Global Healthcare Infection Surveillance Service Players, Product Type & Application
  8. 4.5 Global Healthcare Infection Surveillance Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Healthcare Infection Surveillance Service Market CR5 and HHI
  11. 4.6.3 2025 Healthcare Infection Surveillance Service Tier 1, Tier 2, and Tier 3
5 Healthcare Infection Surveillance Service Market Size by Type
  1. 5.1 Global Healthcare Infection Surveillance Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Healthcare Infection Surveillance Service Revenue by Type (2021-2032)
  3. 5.3 Global Healthcare Infection Surveillance Service Revenue Market Share by Type (2021-2032)
6 Healthcare Infection Surveillance Service Market Size by Application
  1. 6.1 Global Healthcare Infection Surveillance Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Healthcare Infection Surveillance Service Revenue by Application (2021-2032)
  3. 6.3 Global Healthcare Infection Surveillance Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Baxter International Inc.
  2. 7.1.1 Baxter International Inc. Company Information
  3. 7.1.2 Baxter International Inc. Business Overview
  4. 7.1.3 Baxter International Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Baxter International Inc. Healthcare Infection Surveillance Service Product Portfolio
  6. 7.1.5 Baxter International Inc. Recent Developments
  7. 7.2 Wolters Kluwer
  8. 7.2.1 Wolters Kluwer Company Information
  9. 7.2.2 Wolters Kluwer Business Overview
  10. 7.2.3 Wolters Kluwer Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Wolters Kluwer Healthcare Infection Surveillance Service Product Portfolio
  12. 7.2.5 Wolters Kluwer Recent Developments
  13. 7.3 Gojo Industries Inc.
  14. 7.3.1 Gojo Industries Inc. Company Information
  15. 7.3.2 Gojo Industries Inc. Business Overview
  16. 7.3.3 Gojo Industries Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Gojo Industries Inc. Healthcare Infection Surveillance Service Product Portfolio
  18. 7.3.5 Gojo Industries Inc. Recent Developments
  19. 7.4 International Business Machines Corporation
  20. 7.4.1 International Business Machines Corporation Company Information
  21. 7.4.2 International Business Machines Corporation Business Overview
  22. 7.4.3 International Business Machines Corporation Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 International Business Machines Corporation Healthcare Infection Surveillance Service Product Portfolio
  24. 7.4.5 International Business Machines Corporation Recent Developments
  25. 7.5 Premier Inc.
  26. 7.5.1 Premier Inc. Company Information
  27. 7.5.2 Premier Inc. Business Overview
  28. 7.5.3 Premier Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Premier Inc. Healthcare Infection Surveillance Service Product Portfolio
  30. 7.5.5 Premier Inc. Recent Developments
  31. 7.6 Alpha Source Inc.
  32. 7.6.1 Alpha Source Inc. Company Information
  33. 7.6.2 Alpha Source Inc. Business Overview
  34. 7.6.3 Alpha Source Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Alpha Source Inc. Healthcare Infection Surveillance Service Product Portfolio
  36. 7.6.5 Alpha Source Inc. Recent Developments
  37. 7.7 RLDatixS. C.
  38. 7.7.1 RLDatixS. C. Company Information
  39. 7.7.2 RLDatixS. C. Business Overview
  40. 7.7.3 RLDatixS. C. Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 RLDatixS. C. Healthcare Infection Surveillance Service Product Portfolio
  42. 7.7.5 RLDatixS. C. Recent Developments
  43. 7.8 BD
  44. 7.8.1 BD Company Information
  45. 7.8.2 BD Business Overview
  46. 7.8.3 BD Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BD Healthcare Infection Surveillance Service Product Portfolio
  48. 7.8.5 BD Recent Developments
  49. 7.9 BioVigil
  50. 7.9.1 BioVigil Company Information
  51. 7.9.2 BioVigil Business Overview
  52. 7.9.3 BioVigil Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioVigil Healthcare Infection Surveillance Service Product Portfolio
  54. 7.9.5 BioVigil Recent Developments
  55. 7.10 Johnson & Son
  56. 7.10.1 Johnson & Son Company Information
  57. 7.10.2 Johnson & Son Business Overview
  58. 7.10.3 Johnson & Son Healthcare Infection Surveillance Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Johnson & Son Healthcare Infection Surveillance Service Product Portfolio
  60. 7.10.5 Johnson & Son Recent Developments
8 North America
  1. 8.1 North America Healthcare Infection Surveillance Service Revenue (2021-2032)
  2. 8.2 North America Healthcare Infection Surveillance Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Healthcare Infection Surveillance Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Healthcare Infection Surveillance Service Revenue by Type (2027-2032)
  5. 8.3 North America Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Healthcare Infection Surveillance Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Healthcare Infection Surveillance Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Healthcare Infection Surveillance Service Revenue by Application (2027-2032)
  9. 8.5 North America Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Healthcare Infection Surveillance Service Revenue by Country
  11. 8.6.1 North America Healthcare Infection Surveillance Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Healthcare Infection Surveillance Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Healthcare Infection Surveillance Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Healthcare Infection Surveillance Service Revenue (2021-2032)
  2. 9.2 Europe Healthcare Infection Surveillance Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Healthcare Infection Surveillance Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Healthcare Infection Surveillance Service Revenue by Type (2027-2032)
  5. 9.3 Europe Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Healthcare Infection Surveillance Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Healthcare Infection Surveillance Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Healthcare Infection Surveillance Service Revenue by Application (2027-2032)
  9. 9.5 Europe Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Healthcare Infection Surveillance Service Revenue by Country
  11. 9.6.1 Europe Healthcare Infection Surveillance Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Healthcare Infection Surveillance Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Healthcare Infection Surveillance Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Healthcare Infection Surveillance Service Revenue (2021-2032)
  2. 10.2 China Healthcare Infection Surveillance Service Revenue by Type (2021-2032)
  3. 10.2.1 China Healthcare Infection Surveillance Service Revenue by Type (2021-2026)
  4. 10.2.2 China Healthcare Infection Surveillance Service Revenue by Type (2027-2032)
  5. 10.3 China Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032)
  6. 10.4 China Healthcare Infection Surveillance Service Revenue by Application (2021-2032)
  7. 10.4.1 China Healthcare Infection Surveillance Service Revenue by Application (2021-2026)
  8. 10.4.2 China Healthcare Infection Surveillance Service Revenue by Application (2027-2032)
  9. 10.5 China Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Healthcare Infection Surveillance Service Revenue (2021-2032)
  2. 11.2 Asia Healthcare Infection Surveillance Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Healthcare Infection Surveillance Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Healthcare Infection Surveillance Service Revenue by Type (2027-2032)
  5. 11.3 Asia Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Healthcare Infection Surveillance Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Healthcare Infection Surveillance Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Healthcare Infection Surveillance Service Revenue by Application (2027-2032)
  9. 11.5 Asia Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Healthcare Infection Surveillance Service Revenue by Country
  11. 11.6.1 Asia Healthcare Infection Surveillance Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Healthcare Infection Surveillance Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Healthcare Infection Surveillance Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Healthcare Infection Surveillance Service Revenue (2021-2032)
  2. 12.2 SAMEA Healthcare Infection Surveillance Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Healthcare Infection Surveillance Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Healthcare Infection Surveillance Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Healthcare Infection Surveillance Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Healthcare Infection Surveillance Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Healthcare Infection Surveillance Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Healthcare Infection Surveillance Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Healthcare Infection Surveillance Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Healthcare Infection Surveillance Service Revenue by Country
  11. 12.6.1 SAMEA Healthcare Infection Surveillance Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Healthcare Infection Surveillance Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Healthcare Infection Surveillance Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst